[{"assetId":2132,"namespaceCd":"VA","displayName":"Denosumab (Xgeva) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DenosumabXgevaDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2098,"namespaceCd":"VA","displayName":"Belatacpet (Nulojix) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BelatacpetNulojixDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":1,"namespaceCd":"VA","displayName":"PTSD Assessment","lastUpdateDate":"2015-06-05","assetUrl":"http://www.ptsd.va.gov/professional/pages/assessments/assessment.asp","assetMimeType":"text/html"},{"assetId":2131,"namespaceCd":"VA","displayName":"Denosumab (Prolia) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DenosumabProliaMonograph.doc","assetMimeType":"application/msword"},{"assetId":2099,"namespaceCd":"VA","displayName":"Belimumab Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BelimumabDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2,"namespaceCd":"VA","displayName":"Pharmacologic Management of Chronic Heart Failure in Primary Care","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/chf/chf_full_text.pdf","assetMimeType":"application/pdf"},{"assetId":3,"namespaceCd":"VA","displayName":"Abatacept ","lastUpdateDate":"2013-04-26","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Abatacept.pdf","assetMimeType":"application/pdf"},{"assetId":2134,"namespaceCd":"VA","displayName":"Desvenlafaxine (Pristiq) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DesvenlafaxinePristiqMonograph.doc","assetMimeType":"application/msword"},{"assetId":2100,"namespaceCd":"VA","displayName":"Bendamustine Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BendamustineMonograph.doc","assetMimeType":"application/msword"},{"assetId":2133,"namespaceCd":"VA","displayName":"Desloratadine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Desloratadine.pdf","assetMimeType":"application/pdf"},{"assetId":4,"namespaceCd":"VA","displayName":"Management of Asthma (Adult and Pediatric)","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/asthma/ast_2_sum.pdf","assetMimeType":"application/pdf"},{"assetId":2102,"namespaceCd":"VA","displayName":"Benzylpenicilloyl Polylysine (Pre-Pen) National Drug Monograph-(final)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BenzylpenicilloylPolylysinePrePenNationalDrugMonographfinal.pdf","assetMimeType":"application/pdf"},{"assetId":5,"namespaceCd":"VA","displayName":"Management of Pregnancy","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/WH/up/CPG_Pregnancy_-Sum_final_06_20_2011.pdf","assetMimeType":"application/pdf"},{"assetId":2136,"namespaceCd":"VA","displayName":"Diclofenac Epolamine Patch Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DiclofenacEpolaminePatchMonograph.doc","assetMimeType":"application/msword"},{"assetId":6,"namespaceCd":"VA","displayName":"Diabetes Mellitus Pocket card","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/diabetes/Final_DM_Pocket_Card_Aug2010.pdf","assetMimeType":"application/pdf"},{"assetId":2103,"namespaceCd":"VA","displayName":"Bepotastine Besilate Ophthalmic Solution","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BepotastineBesilateOphthalmicSolution.doc","assetMimeType":"application/msword"},{"assetId":2135,"namespaceCd":"VA","displayName":"Dextromethorphan Hydrobromide and Qunidine Sulfate (Nuedexta) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Dextromethorphan_Hydrobromide_and_Qunidine_Sulfate_Nuedexta_Drug_Monograph.pdf","assetMimeType":"application/pdf"},{"assetId":7,"namespaceCd":"VA","displayName":"Management of Diabetes Mellitus","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/diabetes/DM2010_SUM-v4.pdf","assetMimeType":"application/pdf"},{"assetId":2138,"namespaceCd":"VA","displayName":"Dronedarone","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Dronedarone.pdf","assetMimeType":"application/pdf"},{"assetId":8,"namespaceCd":"VA","displayName":"Self-care skills for the person with diabetes","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/diabetes/24818_48pgs.pdf","assetMimeType":"application/pdf"},{"assetId":2105,"namespaceCd":"VA","displayName":"Bevacizumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Bevacizumab.pdf","assetMimeType":"application/pdf"},{"assetId":2137,"namespaceCd":"VA","displayName":"Difluprednate Ophthalmic Emulsion","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DifluprednateOphthalmicEmulsion.doc","assetMimeType":"application/msword"},{"assetId":2140,"namespaceCd":"VA","displayName":"Ecallantide, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/EcallantideDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":9,"namespaceCd":"VA","displayName":"Shared decision-making with the patient with diabetes","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/diabetes/cpgSDMDMPOCKETFinalPRESS022513.pdf","assetMimeType":"application/pdf"},{"assetId":2106,"namespaceCd":"VA","displayName":"Boceprevir Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BoceprevirMonograph.doc","assetMimeType":"application/msword"},{"assetId":2139,"namespaceCd":"VA","displayName":"Dutasteride","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Dutasteride.pdf","assetMimeType":"application/pdf"},{"assetId":2107,"namespaceCd":"VA","displayName":"Bortezomib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BortezomibDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":10,"namespaceCd":"VA","displayName":"Opioid Therapy pocket card","lastUpdateDate":"2013-04-26","assetUrl":"http://www.healthquality.va.gov/guidelines/Pain/cot/OpioidPocketGuide23May2013v1.pdf","assetMimeType":"application/pdf"},{"assetId":2108,"namespaceCd":"VA","displayName":"Brentuximab Vedotin Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BrentuximabVedotinMonograph.doc","assetMimeType":"application/msword"},{"assetId":2142,"namespaceCd":"VA","displayName":"Eltrombopag","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Eltrombopag.doc","assetMimeType":"application/msword"},{"assetId":4394,"namespaceCd":"hsc.utah.edu","displayName":"Guideline: Kidney Transplant Inpatient Management","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/Lists/Policies/DispForm.aspx?ID=388","assetMimeType":"text/html"},{"assetId":2141,"namespaceCd":"VA","displayName":"Elvitegravir cobicistat tenofovir emtricitabine, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Elvitegravir_cobicistat_tenofovir_emtricitabineDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2109,"namespaceCd":"VA","displayName":"Bromocriptine monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Bromocriptinemonograph.doc","assetMimeType":"application/msword"},{"assetId":2110,"namespaceCd":"VA","displayName":"Buprenorphine, Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/BuprenorphineMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2144,"namespaceCd":"VA","displayName":"Enzalutamide Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/EnzalutamideDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2145,"namespaceCd":"VA","displayName":"Epinastine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Epinastine.pdf","assetMimeType":"application/pdf"},{"assetId":2111,"namespaceCd":"VA","displayName":"C1 Inhibitor (Berinert), Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/C1InhibitorBerinertDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2143,"namespaceCd":"VA","displayName":"Eltrombopag Addendum for Hepatitis C related Thrombocytopenia","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/EltrombopagAddendumforHepatitisC.pdf","assetMimeType":"application/pdf"},{"assetId":2112,"namespaceCd":"VA","displayName":"C1 Inhibitor (Cinryze), Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/C1InhibitorCinryzeDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2113,"namespaceCd":"VA","displayName":"Cabazitaxel Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CabazitaxelDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2147,"namespaceCd":"VA","displayName":"Eszopiclone","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Eszopiclone.pdf","assetMimeType":"application/pdf"},{"assetId":2114,"namespaceCd":"VA","displayName":"Calcitriol Ointment Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CalcitriolOintmentMonograph.doc","assetMimeType":"application/msword"},{"assetId":2146,"namespaceCd":"VA","displayName":"Erlotinib","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Erlotinib.pdf","assetMimeType":"application/pdf"},{"assetId":2083,"namespaceCd":"VA","displayName":"Aclidinium Bromide","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AclidiniumBromide.pdf","assetMimeType":"application/pdf"},{"assetId":2115,"namespaceCd":"VA","displayName":"Capsaicin Patch Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CapsaicinPatchMonograph.doc","assetMimeType":"application/msword"},{"assetId":2256,"namespaceCd":"VA","displayName":"Vilazodone Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/VilazodoneMonograph.doc","assetMimeType":"application/msword"},{"assetId":2082,"namespaceCd":"VA","displayName":"Acamprosate","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AcamprosateMonographandAddendum.pdf","assetMimeType":"application/pdf"},{"assetId":2116,"namespaceCd":"VA","displayName":"Carbidopa-Levodopa-Entacapone (Stalevo)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CarbidopaLevodopaEntacaponeStalevo.pdf","assetMimeType":"application/pdf"},{"assetId":2255,"namespaceCd":"VA","displayName":"Vemurafenib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/VemurafenibDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2258,"namespaceCd":"VA","displayName":"Ziconotide, Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ZiconotideMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2085,"namespaceCd":"VA","displayName":"Aflibercept Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AfliberceptDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2117,"namespaceCd":"VA","displayName":"Ceftaroline","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ceftaroline.doc","assetMimeType":"application/msword"},{"assetId":2257,"namespaceCd":"VA","displayName":"Vitamin Supplement for Macular Degeneration (Ocuvite), Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/VitaminSupplementforMacularDegenerationOcuviteDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2118,"namespaceCd":"VA","displayName":"Centruroides (Scorpion) Immune F(ab)2 (Equine) (Anascorp) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CentruroidesScorpionImmuneFab2EquineAnascorpMonographFinalJanuary2012.doc","assetMimeType":"application/msword"},{"assetId":2084,"namespaceCd":"VA","displayName":"Adalimumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Adalimumab.pdf","assetMimeType":"application/pdf"},{"assetId":2119,"namespaceCd":"VA","displayName":"Certolizumab Pegol Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CertolizumabPegolMonograph.doc","assetMimeType":"application/msword"},{"assetId":2087,"namespaceCd":"VA","displayName":"Alpha 1-Proteinase Inhibitor (Glassia)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Alpha1ProteinaseInhibitorGlassia.doc","assetMimeType":"application/msword"},{"assetId":2260,"namespaceCd":"VA","displayName":"Zoledronic acid (Reclast) Update 10.09","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ZoledronicacidReclastUpdate1009.doc","assetMimeType":"application/msword"},{"assetId":2120,"namespaceCd":"VA","displayName":"Ciclesonide (Omnaris) Drug Monograph-Final-September 2009","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CiclesonideOmnarisDrugMonograph-Final-September2009.doc","assetMimeType":"application/msword"},{"assetId":2086,"namespaceCd":"VA","displayName":"Aliskiren","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Aliskiren.doc","assetMimeType":"application/msword"},{"assetId":2259,"namespaceCd":"VA","displayName":"Ziv-aflibercept, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ZivafliberceptDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2121,"namespaceCd":"VA","displayName":"Collagenase Clostridium Histolyticum Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Collagenase_Clostridium_Histolyticum_Monograph_update_2014.docx","assetMimeType":"application/msword"},{"assetId":2089,"namespaceCd":"VA","displayName":"Ambrisentan, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AmbrisentanDrugMonographOct2008.doc","assetMimeType":"application/msword"},{"assetId":2088,"namespaceCd":"VA","displayName":"Alvimopan Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AlvimopanMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2261,"namespaceCd":"VA","displayName":"Zoledronic Acid (Zometa)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ZoledronicAcidZometa.pdf","assetMimeType":"application/pdf"},{"assetId":2122,"namespaceCd":"VA","displayName":"Conivaptan","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Conivaptan.pdf","assetMimeType":"application/pdf"},{"assetId":2248,"namespaceCd":"VA","displayName":"Tocilizumab Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TocilizumabDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2091,"namespaceCd":"VA","displayName":"Aprepitant Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AprepitantDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2123,"namespaceCd":"VA","displayName":"Cross-Linked Hyaluronate (Gel-One) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CrossLinkedHyaluronateGelOneMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2247,"namespaceCd":"VA","displayName":"Thrombin, Topical (Thrombin JMI, Evithrom, Recothrom) Drug Monograph-Final (December 2008)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ThrombinTopicalThrombinJMIEvithromRecothromDrugMonographFinalDecember2008.doc","assetMimeType":"application/msword"},{"assetId":2090,"namespaceCd":"VA","displayName":"Apixaban Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ApixabanDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2124,"namespaceCd":"VA","displayName":"Cyclosporine Ophthalmic (Restasis) NME","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/CyclosporineOphthalmicRestasisNME.doc","assetMimeType":"application/msword"},{"assetId":2250,"namespaceCd":"VA","displayName":"Tranexamic Acid Oral (Lysteda) Drug Monograph June 2012","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TranexamicAcidOralLystedaDrugMonographJune2012.doc","assetMimeType":"application/msword"},{"assetId":2093,"namespaceCd":"VA","displayName":"Armodafinil, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Armodafinil.docx","assetMimeType":"application/msword"},{"assetId":2125,"namespaceCd":"VA","displayName":"Dalfampridine (Ampyra) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DalfampridineAmpyraDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2249,"namespaceCd":"VA","displayName":"Tolvaptan Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TolvaptanDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2092,"namespaceCd":"VA","displayName":"Aripiprazole IM Monogragh","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Aripiprazole_Long_acting_IM_Monograph.doc","assetMimeType":"application/msword"},{"assetId":2126,"namespaceCd":"VA","displayName":"Dasatinib","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Dasatinib.pdf","assetMimeType":"application/pdf"},{"assetId":2252,"namespaceCd":"VA","displayName":"Ustekinumab (Stelara) NMEM","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/UstekinumabStelaraNMEM.doc","assetMimeType":"application/msword"},{"assetId":2127,"namespaceCd":"VA","displayName":"Dasatinib Monograph Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DasatinibAddendum.pdf","assetMimeType":"application/pdf"},{"assetId":2095,"namespaceCd":"VA","displayName":"Azacitidine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Azacitidine.pdf","assetMimeType":"application/pdf"},{"assetId":2251,"namespaceCd":"VA","displayName":"Treprostinil INHALATION Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TreprostinilINHALATIONDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2128,"namespaceCd":"VA","displayName":"Decitabine Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DecitabineMonograph.doc","assetMimeType":"application/msword"},{"assetId":2094,"namespaceCd":"VA","displayName":"Asenapine Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AsenapineMonograph.doc","assetMimeType":"application/msword"},{"assetId":2129,"namespaceCd":"VA","displayName":"Deferasirox Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DeferasiroxMonograph.doc","assetMimeType":"application/msword"},{"assetId":2254,"namespaceCd":"VA","displayName":"Varenicline","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Varenicline.pdf","assetMimeType":"application/pdf"},{"assetId":2130,"namespaceCd":"VA","displayName":"Degarelix Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/DegarelixMonograph.doc","assetMimeType":"application/msword"},{"assetId":2253,"namespaceCd":"VA","displayName":"Valdecoxib","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Valdecoxib.pdf","assetMimeType":"application/pdf"},{"assetId":2096,"namespaceCd":"VA","displayName":"Azilsartan, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AzilsartanDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2167,"namespaceCd":"VA","displayName":"Icatibant, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IcatibantDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":4369,"namespaceCd":"VA","displayName":"DON'T LET HEPATITIS C SURPRISE YOU","lastUpdateDate":"2015-09-24","assetUrl":"http://www.hepatitis.va.gov/pdf/hepatitisC-infographic.pdf","assetMimeType":"application/pdf"},{"assetId":2166,"namespaceCd":"VA","displayName":"Ibandronate Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IbandronateDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":4370,"namespaceCd":"VA","displayName":"The Alcohol Use Disorders Identification Test","lastUpdateDate":"2015-08-27","assetUrl":"http://www.hepatitis.va.gov/provider/tools/audit-c.asp#S1X","assetMimeType":"text/html"},{"assetId":2165,"namespaceCd":"VA","displayName":"Hydroxyethyl Starch 130-0.4 (Voluven) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/HydroxyethylStarch13004VoluvenMonograph.doc","assetMimeType":"application/msword"},{"assetId":4371,"namespaceCd":"VA","displayName":"Scoring Cards for Men","lastUpdateDate":"2015-08-27","assetUrl":"http://www.hepatitis.va.gov/pdf/Audit_C_Cards_Male_IB_10-346_web.pdf","assetMimeType":"application/pdf"},{"assetId":2164,"namespaceCd":"VA","displayName":"Hyaluronidase Monograph (Amphadase, Hydase, Vitrase, Hylenex) Final","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/HyaluronidaseMonographAmphadaseHydaseVitraseHylenexFinal.doc","assetMimeType":"application/msword"},{"assetId":4372,"namespaceCd":"VA","displayName":"Scoring Cards for Women","lastUpdateDate":"2015-08-27","assetUrl":"http://www.hepatitis.va.gov/pdf/AUDIT_C_Cards_Female_IB_10-347_web.pdf","assetMimeType":"application/pdf"},{"assetId":4373,"namespaceCd":"VA","displayName":"Analgesia and anesthesia for the breastfeeding mother, revised 2012.","lastUpdateDate":"2015-08-27","assetUrl":"http://www.guideline.gov/content.aspx?id=39271","assetMimeType":"text/html"},{"assetId":2171,"namespaceCd":"VA","displayName":"Immune Globulin, Subcutaneous Liquid","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ImmuneGlobulinSubcutaneousLiquid.doc","assetMimeType":"application/msword"},{"assetId":4374,"namespaceCd":"VA","displayName":"ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012","lastUpdateDate":"2015-08-27","assetUrl":"http://www.ncbi.nlm.nih.gov/pubmed/23215911?dopt=Abstract","assetMimeType":"text/html"},{"assetId":2170,"namespaceCd":"VA","displayName":"Imatinib Monograph and Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ImatinibMonographandAddendum.pdf","assetMimeType":"application/pdf"},{"assetId":2169,"namespaceCd":"VA","displayName":"Iloprost","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Iloprost.pdf","assetMimeType":"application/pdf"},{"assetId":2168,"namespaceCd":"VA","displayName":"Iloperidone Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IloperidoneMonograph.doc","assetMimeType":"application/msword"},{"assetId":2175,"namespaceCd":"VA","displayName":"Intravenous Ibuprofen (Caldolor)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IntravenousIbuprofenCaldolor.doc","assetMimeType":"application/msword"},{"assetId":2174,"namespaceCd":"VA","displayName":"Intranasal Ketorolac (Sprix) Monograph-Final","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IntranasalKetorolacSprixMonographFinal.doc","assetMimeType":"application/msword"},{"assetId":4362,"namespaceCd":"hsc.utah.edu","displayName":"Acute Knee Pain Pathway","lastUpdateDate":"2015-07-31","assetUrl":"https://pulse.utah.edu/policies/CarePathwaysLibrary/Acute%20Knee%20Pain%20NON-TRAUMATIC%20Clinical%20Pathway.pdf","assetMimeType":"application/pdf"},{"assetId":2173,"namespaceCd":"VA","displayName":"Interferon beta 1b (Extavia) Abbreviated Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Interferonbeta1bExtaviaAbbreviatedDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2172,"namespaceCd":"VA","displayName":"Indacaterol","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Indacaterol.pdf","assetMimeType":"application/pdf"},{"assetId":4364,"namespaceCd":"VA","displayName":"UNIFORM MENTAL HEALTH SERVICES IN VA MEDICAL CENTERS AND CLINICS","lastUpdateDate":"2015-08-27","assetUrl":"http://www.mirecc.va.gov/VISN16/docs/UMHS_Handbook_1160.pdf","assetMimeType":"application/pdf"},{"assetId":4365,"namespaceCd":"VA","displayName":"MILITARY SEXUAL TRAUMA (MST) PROGRAMMING","lastUpdateDate":"2015-08-27","assetUrl":"http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2272","assetMimeType":"application/pdf"},{"assetId":2180,"namespaceCd":"VA","displayName":"Lenalidomide Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/LenalidomideDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2081,"namespaceCd":"VA","displayName":"Abiraterone Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/AbirateroneMonograph.doc","assetMimeType":"application/msword"},{"assetId":4366,"namespaceCd":"VA","displayName":"HOW TO SCREEN FOR HEAVY DRINKING","lastUpdateDate":"2015-08-27","assetUrl":"http://www.hiv.va.gov/pdf/pcm-alcohol-f01.pdf","assetMimeType":"application/pdf"},{"assetId":2179,"namespaceCd":"VA","displayName":"Lapatinib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/LapatinibDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2178,"namespaceCd":"VA","displayName":"Ixabepilone Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IxabepiloneDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":4367,"namespaceCd":"VA","displayName":"Screening for Abdominal Aortic Aneurysm","lastUpdateDate":"2015-08-27","assetUrl":"http://www.prevention.va.gov/docs/AHRQ_Partnership_Health/AAA_providerF.pdf","assetMimeType":"application/pdf"},{"assetId":2176,"namespaceCd":"VA","displayName":"Ipilimumab Monograph Final","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IpilimumabMonographFinal.doc","assetMimeType":"application/msword"},{"assetId":2177,"namespaceCd":"VA","displayName":"Ivermectin Topical Lotion","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/IvermectinTopicalLotion.doc","assetMimeType":"application/msword"},{"assetId":4368,"namespaceCd":"VA","displayName":"Hepatitis C Information for Providers","lastUpdateDate":"2015-08-27","assetUrl":"http://www.hepatitis.va.gov/pdf/Hepatitis-C-Factsheet-Providers.pdf","assetMimeType":"application/pdf"},{"assetId":2150,"namespaceCd":"VA","displayName":"Exenatide Extended-Release","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ExenatideExtendedRelease.doc","assetMimeType":"application/msword"},{"assetId":4387,"namespaceCd":"hsc.utah.edu","displayName":"Patient Complaint Process","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/document_center/Documents/patientcomplaintaddenda.pdf","assetMimeType":"application/pdf"},{"assetId":2151,"namespaceCd":"VA","displayName":"Ezetimibe","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ezetimibe.pdf","assetMimeType":"application/pdf"},{"assetId":4386,"namespaceCd":"hsc.utah.edu","displayName":"CDC Hand Hygiene Patient Brochure","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/document_center/Documents/Hand%20Hygiene%20Patient%20Brochure%20-%20English%20(CDC).pdf","assetMimeType":"application/pdf"},{"assetId":2148,"namespaceCd":"VA","displayName":"Etravirine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Etravirine.doc","assetMimeType":"application/msword"},{"assetId":4389,"namespaceCd":"hsc.utah.edu","displayName":"Headaches in Pregnancy","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/Lists/Policies/DispForm.aspx?ID=326","assetMimeType":"text/html"},{"assetId":2149,"namespaceCd":"VA","displayName":"Everolimus Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/EverolimusDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":4388,"namespaceCd":"hsc.utah.edu","displayName":"Alternatives to nadolol","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/qandas/Lists/QuestionsAnswers/DispForm.aspx?ID=1676","assetMimeType":"text/html"},{"assetId":2154,"namespaceCd":"VA","displayName":"Ferumoxytol","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ferumoxytol.pdf","assetMimeType":"application/pdf"},{"assetId":4391,"namespaceCd":"hsc.utah.edu","displayName":"Guideline: Pulmonary Embolism Care Pathway Algorithms","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/Lists/Policies/DispForm.aspx?ID=10028","assetMimeType":"text/html"},{"assetId":2155,"namespaceCd":"VA","displayName":"Fidaxomicin Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FidaxomicinMonograph.doc","assetMimeType":"application/msword"},{"assetId":4390,"namespaceCd":"hsc.utah.edu","displayName":"Concussion Pathway Diagram","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/CarePathwaysLibrary/Concussion%20Pathway%20Diagram.pd","assetMimeType":"application/pdf"},{"assetId":2152,"namespaceCd":"VA","displayName":"Factor VII, Recombinant Activated (NovoSeven?), Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FactorVIIRecombinantActivatedNovoSevenDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":4393,"namespaceCd":"hsc.utah.edu","displayName":"Protocol: Sedation (SICU)","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/Lists/Policies/DispForm.aspx?ID=1304","assetMimeType":"text/html"},{"assetId":4392,"namespaceCd":"hsc.utah.edu","displayName":"Acute Concussion Clinical Pathway","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/CarePathwaysLibrary/Concussion%20Pathway%20Diagram.pdf#search=care%20pathway","assetMimeType":"application/pdf"},{"assetId":2153,"namespaceCd":"VA","displayName":"Febuxostat","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Febuxostat.doc","assetMimeType":"application/msword"},{"assetId":2158,"namespaceCd":"VA","displayName":"Fondaparinux Monograph and Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FondaparinuxMonographandAddendum.pdf","assetMimeType":"application/pdf"},{"assetId":2159,"namespaceCd":"VA","displayName":"Fospropofol (Lusedra) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FospropofolLusedraMonograph.doc","assetMimeType":"application/msword"},{"assetId":4380,"namespaceCd":"hsc.utah.edu","displayName":"test - asthma","lastUpdateDate":"2015-09-21","assetUrl":null,"assetMimeType":"application/pdf"},{"assetId":2156,"namespaceCd":"VA","displayName":"Fingolimod (Gilenya)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FingolimodGilenya.doc","assetMimeType":"application/msword"},{"assetId":2157,"namespaceCd":"VA","displayName":"Fondaparinux Addendum (2nd update, July 2008)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/FondaparinuxAddendum2ndupdateJuly2008.doc","assetMimeType":"application/msword"},{"assetId":2162,"namespaceCd":"VA","displayName":"Ganciclovir Ophthalmic Gel","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/GanciclovirOphthalmicGel.doc","assetMimeType":"application/msword"},{"assetId":4382,"namespaceCd":"hsc.utah.edu","displayName":"Acute Knee Pain Pathway - permalink","lastUpdateDate":"2015-09-24","assetUrl":"https://pulse.utah.edu/policies/_layouts/15/DocIdRedir.aspx?ID=PULSEDOC-52-67","assetMimeType":"application/pdf"},{"assetId":2163,"namespaceCd":"VA","displayName":"Golimumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Golimumab.doc","assetMimeType":"application/msword"},{"assetId":4384,"namespaceCd":"hsc.utah.edu","displayName":"Guideline: Inpatient Thrombosis Service Pharmacist Anticoagulation Management Protocol","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/policies/Lists/Policies/DispForm.aspx?id=3600","assetMimeType":"text/html"},{"assetId":2160,"namespaceCd":"VA","displayName":"Fulvestrant","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Fulvestrant.pdf","assetMimeType":"application/pdf"},{"assetId":4385,"namespaceCd":"hsc.utah.edu","displayName":"MyChart FAQ","lastUpdateDate":"2015-09-30","assetUrl":"https://pulse.utah.edu/site/ITT/_layouts/15/WopiFrame.aspx?sourcedoc=/site/ITT/SitePages/FAQ%20-%20MyChart.docx&action=default&DefaultItemOpen=1","assetMimeType":"application/msword"},{"assetId":4383,"namespaceCd":"hsc.utah.edu","displayName":"Seizure Care Pathway Algorithm 1 & 2","lastUpdateDate":"2015-09-28","assetUrl":"https://pulse.utah.edu/policies/CarePathwaysLibrary/Seizure%20Care%20Pathway.pdf","assetMimeType":"application/pdf"},{"assetId":2161,"namespaceCd":"VA","displayName":"Gabapentin Enacarbil (Horizant) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/GabapentinEnacarbilHorizantDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2202,"namespaceCd":"VA","displayName":"Oxybutynin Extended Release","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/OxybutyninExtendedRelease.doc","assetMimeType":"application/msword"},{"assetId":2201,"namespaceCd":"VA","displayName":"Oxaliplatin Monograph and Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/OxaliplatinMonographandAddendum.pdf","assetMimeType":"application/pdf"},{"assetId":2198,"namespaceCd":"VA","displayName":"Olanzapine pamoate (LA IM) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/OlanzapinepamoateLAIMMonograph.doc","assetMimeType":"application/msword"},{"assetId":2197,"namespaceCd":"VA","displayName":"Ofatumumab Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/OfatumumabMonograph.doc","assetMimeType":"application/msword"},{"assetId":2200,"namespaceCd":"VA","displayName":"Orlistat","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Orlistat.pdf","assetMimeType":"application/pdf"},{"assetId":2199,"namespaceCd":"VA","displayName":"Omega-3-acid ethyl esters (Lovaza?, formerly Omacor)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Omega3acidethylestersLovazaformerlyOmacor.pdf","assetMimeType":"application/pdf"},{"assetId":2211,"namespaceCd":"VA","displayName":"Pemetrexed","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Pemetrexed.pdf","assetMimeType":"application/pdf"},{"assetId":2210,"namespaceCd":"VA","displayName":"Pegloticase (Krystexxa) Monograph-Final","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PegloticaseKrystexxaMonographFinal.doc","assetMimeType":"application/msword"},{"assetId":2213,"namespaceCd":"VA","displayName":"Phentermine Topiramate Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PhenterminTopiramateMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2212,"namespaceCd":"VA","displayName":"Pitavastatin (Livalo) Monograph-final","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PitavastatinLivaloMonographfinal.doc","assetMimeType":"application/msword"},{"assetId":2206,"namespaceCd":"VA","displayName":"Panitumumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Panitumumab.pdf","assetMimeType":"application/pdf"},{"assetId":2205,"namespaceCd":"VA","displayName":"Paliperidone palmitate IM Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PaliperidonepalmitateIMMonograph.doc","assetMimeType":"application/msword"},{"assetId":2209,"namespaceCd":"VA","displayName":"Peginesatide, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PeginesatideDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2208,"namespaceCd":"VA","displayName":"Pazopanib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PazopanibDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2207,"namespaceCd":"VA","displayName":"Papain Urea","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PapainUrea.pdf","assetMimeType":"application/pdf"},{"assetId":4350,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - ischemic heart disease","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960A-1-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2185,"namespaceCd":"VA","displayName":"Lorcaserine Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/LorcaserinMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":4351,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - hypertension","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960A-3-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2186,"namespaceCd":"VA","displayName":"Lubiprostone","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Lubiprostone.pdf","assetMimeType":"application/pdf"},{"assetId":2187,"namespaceCd":"VA","displayName":"Lurasidone (Latuda) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/LurasidoneLatudaMonograph.doc","assetMimeType":"application/msword"},{"assetId":2188,"namespaceCd":"VA","displayName":"Methylnaltrexone Inj Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/MethylnaltrexoneInjMonograph.doc","assetMimeType":"application/msword"},{"assetId":2181,"namespaceCd":"VA","displayName":"Lidocaine Ophthalmic Gel","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/LidocaineOphthalmicGel.doc","assetMimeType":"application/msword"},{"assetId":4346,"namespaceCd":"VA","displayName":"VHA Maternity Care Handbook","lastUpdateDate":"2014-08-22","assetUrl":"http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2803","assetMimeType":"application/pdf"},{"assetId":2182,"namespaceCd":"VA","displayName":"Linagliptin monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Linagliptinmonograph.pdf","assetMimeType":"application/pdf"},{"assetId":4347,"namespaceCd":"VA","displayName":"Drugs with FDA risk-in-pregnancy category","lastUpdateDate":"2014-08-22","assetUrl":"https://va.cmopnational.va.gov/cmop/PBM/pre/Shared%20Documents/TDrug%20Reports%20from%20NDDF_DIF%20via%20SQL/FDB%20TDrug%20and%20Lactation%20Data%20with%20NDF%20Matches%20SQL%20CONNECTION.xlsx","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2183,"namespaceCd":"VA","displayName":"Liraglutide monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Liraglutidemonograph.pdf","assetMimeType":"application/pdf"},{"assetId":4345,"namespaceCd":"VA","displayName":"Due date calculator","lastUpdateDate":"2014-08-22","assetUrl":"http://sogc.org/publications-resources/due-date-calculator/","assetMimeType":"text/html"},{"assetId":2184,"namespaceCd":"VA","displayName":"Lisdexamfetamine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Lisdexamfetamine.doc","assetMimeType":"application/msword"},{"assetId":2193,"namespaceCd":"VA","displayName":"Nelarabine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Nelarabine.pdf","assetMimeType":"application/pdf"},{"assetId":2194,"namespaceCd":"VA","displayName":"Nepafenac","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Nepafenac.pdf","assetMimeType":"application/pdf"},{"assetId":2195,"namespaceCd":"VA","displayName":"Nilotinib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/NilotinibDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":4357,"namespaceCd":"VA","displayName":"Hip & Knee Osteoarthritis: Summary","lastUpdateDate":"2015-07-06","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/OA/VADoDOAClinicianSummaryFINAL090214.pdf","assetMimeType":"application/pdf"},{"assetId":2196,"namespaceCd":"VA","displayName":"Ocriplasmin Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ocriplasmin_Drug_Monograph.pdf","assetMimeType":"application/pdf"},{"assetId":4358,"namespaceCd":"hsc.utah.edu","displayName":"Hypertension: Clinician Guideline Summary","lastUpdateDate":"2015-07-31","assetUrl":"http://www.healthquality.va.gov/guidelines/CD/htn/VADoDHTNClinicianSummary.pdf","assetMimeType":"text/html"},{"assetId":2189,"namespaceCd":"VA","displayName":"Milnacipran (revised 2010 09 13)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Milnacipranrevised20100913.doc","assetMimeType":"application/msword"},{"assetId":4355,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - headaches","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960C-8-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2190,"namespaceCd":"VA","displayName":"Mirabegron Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/MirabegronMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":4356,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - esophageal conditions","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960G-1-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2191,"namespaceCd":"VA","displayName":"Mycophenolate Sodium (Myfortic)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/MycophenolateSodiumMyfortic.pdf","assetMimeType":"application/pdf"},{"assetId":4352,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - diabetes","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960E-1-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":4353,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - PTSD","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960P-3-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2192,"namespaceCd":"VA","displayName":"Natalizumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Natalizumab.doc","assetMimeType":"application/msword"},{"assetId":4354,"namespaceCd":"VA","displayName":"Disability benefits questionnaire - heart conditions","lastUpdateDate":"2014-09-04","assetUrl":"http://www.vba.va.gov/pubs/forms/VBA-21-0960A-4-ARE.pdf","assetMimeType":"application/vnd.openxmlformats-officedocument.spre"},{"assetId":2237,"namespaceCd":"VA","displayName":"Sorafenib in Hepatocellular Carcinoma, Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SorafenibinHepatocellularCarcinomaAddendum.doc","assetMimeType":"application/msword"},{"assetId":2236,"namespaceCd":"VA","displayName":"Sipuleucel-T Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SipuleucelTDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2235,"namespaceCd":"VA","displayName":"Silodosin (Rapaflo) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SilodosinRapafloDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2234,"namespaceCd":"VA","displayName":"Sevelamer Carbonate Powder, Abbreviated Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SevelamerCarbonatePowderAbbreviatedDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2233,"namespaceCd":"VA","displayName":"Saxagliptin monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Saxagliptinmonograph.doc","assetMimeType":"application/msword"},{"assetId":2232,"namespaceCd":"VA","displayName":"Rotigotine (Neupro) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RotigotineNeuproNMEMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2231,"namespaceCd":"VA","displayName":"Rosuvastatin","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Rosuvastatin.pdf","assetMimeType":"application/pdf"},{"assetId":2230,"namespaceCd":"VA","displayName":"Romiplostim (Nplate) Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RomiplostimNplateDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2246,"namespaceCd":"VA","displayName":"Tetrabenazine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Tetrabenazine.doc","assetMimeType":"application/msword"},{"assetId":2245,"namespaceCd":"VA","displayName":"Tesamorelin","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Tesamorelin.doc","assetMimeType":"application/msword"},{"assetId":2244,"namespaceCd":"VA","displayName":"Teriflunomide Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TeriflunomideDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2243,"namespaceCd":"VA","displayName":"Telavancin","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Telavancin.doc","assetMimeType":"application/msword"},{"assetId":2242,"namespaceCd":"VA","displayName":"Telaprevir Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TelaprevirMonograph.doc","assetMimeType":"application/msword"},{"assetId":2241,"namespaceCd":"VA","displayName":"Tapentadol IR (Nucynta) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/TapentadolIRNucyntaMonograph.doc","assetMimeType":"application/msword"},{"assetId":2240,"namespaceCd":"VA","displayName":"Sunitinib","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Sunitinib.pdf","assetMimeType":"application/pdf"},{"assetId":2239,"namespaceCd":"VA","displayName":"Spinosad Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SpinosadMonograph.doc","assetMimeType":"application/msword"},{"assetId":2238,"namespaceCd":"VA","displayName":"Sorafenib, Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/SorafenibMonograph.doc","assetMimeType":"application/msword"},{"assetId":2220,"namespaceCd":"VA","displayName":"Ranibizumab","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ranibizumab.pdf","assetMimeType":"application/pdf"},{"assetId":2221,"namespaceCd":"VA","displayName":"Ranolazine","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ranolazine.pdf","assetMimeType":"application/pdf"},{"assetId":2218,"namespaceCd":"VA","displayName":"Ramelteon","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Ramelteon.pdf","assetMimeType":"application/pdf"},{"assetId":2219,"namespaceCd":"VA","displayName":"Ranibizumab Monograph Addendum","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RanibizumabMonographAddendum.doc","assetMimeType":"application/msword"},{"assetId":2216,"namespaceCd":"VA","displayName":"Prasugrel Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PrasugrelMonograph.doc","assetMimeType":"application/msword"},{"assetId":2217,"namespaceCd":"VA","displayName":"Pregabalin Monograph (Rev 2008 02 12)","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PregabalinMonographRev20080212.doc","assetMimeType":"application/msword"},{"assetId":2214,"namespaceCd":"VA","displayName":"Picosulfate - Magnesium Oxide - Citric Acid (PREPOPIK) Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PicosulfateMagnesiumOxideCitricAcidPREPOPIKMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2215,"namespaceCd":"VA","displayName":"Pralatrexate Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/PralatrexateMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2228,"namespaceCd":"VA","displayName":"Rivaroxaban Drug Monograph Addendum for Treatment of Venous Thromboembolism","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RivaroxabanDrugMonographAddendumforTreatmentofVenousThromboembolism.doc","assetMimeType":"application/msword"},{"assetId":2229,"namespaceCd":"VA","displayName":"Roflumilast monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Roflumilastmonograph.doc","assetMimeType":"application/msword"},{"assetId":2226,"namespaceCd":"VA","displayName":"Riluzole","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Riluzole.doc","assetMimeType":"application/msword"},{"assetId":2227,"namespaceCd":"VA","displayName":"Rivaroxaban Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RivaroxabanDrugMonograph.doc","assetMimeType":"application/msword"},{"assetId":2224,"namespaceCd":"VA","displayName":"Regorafenib Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RegorafenibDrugMonograph.pdf","assetMimeType":"application/pdf"},{"assetId":2225,"namespaceCd":"VA","displayName":"Rilpivirine and co-formulated rilpivirine with TDF-FTC monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RilpivirineandcoformulatedrilpivirinewithTDFFTCmonograph.doc","assetMimeType":"application/msword"},{"assetId":2222,"namespaceCd":"VA","displayName":"Rasagiline (Azilect)addendum 03 22 11","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RasagilineAzilectaddendum032211.doc","assetMimeType":"application/msword"},{"assetId":2223,"namespaceCd":"VA","displayName":"Regadenoson, Drug Monograph","lastUpdateDate":"2013-08-23","assetUrl":"http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/RegadenosonDrugMonograph.doc","assetMimeType":"application/msword"}]